MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Chu, Yin Hung ^a   Hsieh, Ming Ju ^a,b   Chiou, Hui Ling ^a   Liou, Yi Sheng ^c,d   Yang, Chen Chieh ^e   Yang, Shun Fa ^a,f   Kuo, Wu Hsien ^g  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e Mennonite Christian Hospital   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196; MICRORNA 499; UNCLASSIFIED DRUG; MIRN499 MICRORNA, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ADVERSE EFFECTS; DRINKING BEHAVIOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; ODDS RATIO;

ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MICRORNAS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REAL-TIME POLYMERASE CHAIN REACTION; SMOKING;

EID: 84896331195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089930     Document Type: Article

References (51)

1. Zhuang L, Zeng X, Yang Z, Meng Z (2013) Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis. PLoS One 8: e61361.
2. Weinmann A, Koch S, Niederle IM, Schulze-Bergkamen H, König J, et al. (2013) Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009: An Analysis of 1066 Cases of a German HCC Registry. J Clin Gastroenterol in press.
3. Huang YW, Wang TC, Lin SC, Chang HY, Chen DS, et al. (2013) Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with new onset diabetes: A nationwide cohort study. Clin Infect Dis 57: 1695-1702.
4. Yin J, Zhang H, He Y, Xie J, Liu S, et al. (2010) Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev 19: 777-786.
5. Zhang Q, Cao G (2011) Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis. Hepat Mon 11: 86-91.
6. Bartel DP (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 116: 281-297.
7. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
8. Feng MJ, Shi F, Qiu C, Peng WK (2012) MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma. Int Immunopharmacol 13: 347-353.
9. Perry MM, Baker JE, Gibeon DS, Adcock IM, Chung KF (2014) Airway Smooth Muscle Hyperproliferation is Regulated by microRNA-221 in Severe Asthma. Am J Respir Cell Mol Biol 50: 7-17.
10. de Rinaldis E, Gazinska P, Mera A, Modrusan Z, Fedorowicz GM, et al. (2013) Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control. BMC Genomics 14: 643.
11. Sureban SM, May R, Qu D, Weygant N, Chandrakesan P, et al. (2013) DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer. PLoS One 8: e73940.
12. Zhao G, Zhang JG, Shi Y, Qin Q, Liu Y, et al. (2013) MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3. PLoS One 8: e73803.
13. Li T, Leong MH, Harms B, Kennedy G, Chen L (2013) MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol 19: 5615-5621.
14. Xu L, Zhou X, Qiu MT, Yin R, Wu YQ, et al. (2013) Lack of Association between Hsa-miR-149 rs2292832 Polymorphism and Cancer Risk: A Meta-Analysis of 12 Studies. PLoS One 8: e73762.
15. Linhares JJ, Azevedo M Jr, Siufi AA, de Carvalho CV, Wolgien Mdel C, et al. (2012) Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer. BMC Med Genet 13: 119.
16. Zheng J, Deng J, Xiao M, Yang L, Zhang L, et al. (2013) A Sequence Polymorphism in miR-608 Predicts Recurrence after Radiotherapy for Nasopharyngeal Carcinoma. Cancer Res 73: 5151-5162.
17. Sabina S, Pulignani S, Rizzo M, Cresci M, Vecoli C, et al. (2013) Germline hereditary, somatic mutations and microRNAs targeting-SNPs in congenital heart defects. J Mol Cell Cardiol 60: 84-89.
18. Zhong S, Chen Z, Xu J, Li W, Zhao J (2013) Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 40: 3181-3186.
19. de Larrea CF, Navarro A, Tejero R, Tovar N, Díaz T, et al. (2012) Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. Clin Cancer Res 18: 3697-3704.
20. Serrano NA, Xu C, Liu Y, Wang P, Fan W, et al. (2012) Integrative analysis in oral squamous cell carcinoma reveals DNA copy number-associated miRNAs dysregulating target genes. Otolaryngol Head Neck Surg 147: 501-508.
21. Liu Z, Wei S, Ma H, Zhao M, Myers JN, et al. (2011) A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 32: 1668-1674.
22. Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, et al. (2012) The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis 33: 581-586.
23. Liu CJ, Shen WG, Peng SY, Cheng HW, Kao SY, et al. (2014) miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer 134: 811-821.
24. Rani SB, Rathod SS, Karthik S, Kaur N, Muzumdar D, et al. (2013) MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro Oncol 15: 1302-1316.
25. Jeon YJ, Kim OJ, Kim SY, Oh SH, Oh D, et al. (2013) Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk. Arterioscler Thromb Vasc Biol 33: 420-430.
26. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, et al. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208: 1189-1201.
27. Wang F, Ma YL, Zhang P, Shen TY, Shi CZ, et al. (2013) SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J Pathol 229: 12-24.
28. Schotte D, Lange-Turenhout EA, Stumpel DJ, Stam RW, Buijs-Gladdines JG, et al. (2010) Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica 95: 1675-1682.
29. Liu X, Zhang Z, Sun L, Chai N, Tang S, et al. (2011) MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 32: 1798-1805.
30. Yu YL, Su KJ, Chen CJ, Wei CW, Lin CJ, et al. (2012) Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells. J Cell Physiol 227: 213-222.
31. Chu YH, Tzeng SL, Lin CW, Chien MH, Chen MK, et al. (2012) Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer. PLoS One 7: e39777.
32. Wei CW, Lin CC, Yu YL, Lin CY, Lin PC, et al. (2009) n- Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2alpha and telomerase activity. Acta Pharmacol Sin 30: 1297-1306.
33. Wang F, Sun G, Zou Y, Li Y, Hao L, et al. (2012) Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PLoS One 7: e45042.
34. Wang Y, Yang B, Ren X (2012) Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case-control studies. Gene 509: 267-272.
35. Xiang Y, Fan S, Cao J, Huang S, Zhang LP (2012) Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 39: 7019-7023.
36. Qiu MT, Hu JW, Ding XX, Yang X, Zhang Z, et al. (2012) Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PLoS One 7: e50887.
37. Chen P, Zhang J, Zhou F (2012) miR-499 rs3746444 polymorphism is associated with cancer development among Asians and related to breast cancer susceptibility. Mol Biol Rep 39: 10433-10438.
38. Wang L, Qian S, Zhi H, Zhang Y, Wang B, et al. (2012) The association between hsa-miR-499 T>C polymorphism and cancer risk: a meta-analysis. Gene 508: 9-14.
39. Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, et al. (2012) Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 143: 811-820.
40. Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, et al. (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123: 2143-2154.
41. Matysiak M, Fortak-Michalska M, Szymanska B, Orlowski W, Jurewicz A, et al. (2013) MicroRNA-146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin E2 synthase-2. J Immunol 190: 5102-5109.
42. Ichii O, Otsuka S, Sasaki N, Namiki Y, Hashimoto Y, et al. (2012) Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int 81: 280-292.
43. Yang L, Boldin MP, Yu Y, Liu CS, Ea CK, et al. (2012) miR-146a controls the resolution of T cell responses in mice. J Exp Med 209: 1655-1670.
44. Koehler EM, Sanna D, Hansen BE, van Rooij FJ, Heeringa J, et al. (2014) Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int 34: 296-304.
45. Tu HF, Liu CJ, Chang CL, Wang PW, Kao SY, et al. (2012) The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma. PLoS One 7: e51606.
46. Øster B, Linnet L, Christensen LL, Thorsen K, Ongen H, et al. (2013) Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer. Int J Cancer 132: 2303-2315.
47. Jin L, Hu WL, Jiang CC, Wang JX, Han CC, et al. (2011) MicroRNA-149, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci U S A 108: 15840-15845.
48. Li Y, Zhang M, Chen H, Dong Z, Ganapathy V, et al. (2010) Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res 70: 7894-7904.
49. Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q (2011) MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med 15: 14-23.
50. Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, et al. (2009) Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113: 3314-3322.
51. Han Y, Pu R, Han X, Zhao J, Zhang Y, et al. (2013) Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One 8: e58564.